Isbell, L.K., Burger, E., Dopatka, T., Scherer, F.P., Orban, A., Lauer, E.M., Malenica, N., Semenova, I., Vreden, A., Fricker, H., El Rabih, A.A.H., Bleul, S., Weis, J., Wirtz, S., Ihorst, G., Finke, J. und Schorb, E. (2023) Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial [cd]. Freiburg: Universität. doi:10.1186/s12885-023-11193-7.

Isbell, Lisa K., Elvira Burger, Tatja Dopatka, Florian Paul Scherer, Andras Orban, Eliza Maria Lauer, Natalie Malenica, Inna Semenova, Annika Vreden, Heidi Fricker, Abed Al Hadi El Rabih, Sabine Bleul, Joachim Weis, Sebastian Wirtz, Gabriele Ihorst, Jürgen Finke, und Elisabeth Schorb. Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial. Cd. Freiburg: Universität, [2023?], Freiburg: Universität, [2023?]. https://doi.org/10.1186/s12885-023-11193-7.

Isbell, L. K., Burger, E., Dopatka, T., Scherer, F. P., Orban, A., Lauer, E. M., Malenica, N., Semenova, I., Vreden, A., Fricker, H., El Rabih, A. A. H., Bleul, S., Weis, J., Wirtz, S., Ihorst, G., Finke, J., & Schorb, E. (ca. 2023). Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial [Cd]. Universität. https://doi.org/10.1186/s12885-023-11193-7

Isbell, L. K., E. Burger, T. Dopatka, F. P. Scherer, A. Orban, E. M. Lauer, N. Malenica, I. Semenova, A. Vreden, H. Fricker, A. A. H. El Rabih, S. Bleul, J. Weis, S. Wirtz, G. Ihorst, J. Finke, und E. Schorb. Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial. cd, Universität, 2023, https://doi.org/10.1186/s12885-023-11193-7.

ISBELL, Lisa K., Elvira BURGER, Tatja DOPATKA, Florian Paul SCHERER, Andras ORBAN, Eliza Maria LAUER, Natalie MALENICA, Inna SEMENOVA, Annika VREDEN, Heidi FRICKER, Abed Al Hadi EL RABIH, Sabine BLEUL, Joachim WEIS, Sebastian WIRTZ, Gabriele IHORST, Jürgen FINKE und Elisabeth SCHORB, 2023. Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial. Freiburg: Universität